FibroBiologics, Inc. — SEC Form D Filing

FibroBiologics, Inc. filed an SEC Form D on December 16, 2025, reporting $1.73M raised in Pharmaceuticals.

Form D filing details

Filing
SEC Form D
Filing date
December 16, 2025
Amount reported
$1.73M
Round stage
Seed
Industry
Pharmaceuticals
Website
https://fibrobiologics.com

What the company does

Securities: Equity. Exemption: Rule 506(b). Incorporated: DELAWARE

Problem

The provided website content is exclusively a cookie consent banner and does not contain information about FibroBiologics, Inc.'s actual business, products, or services.

Solution

Based solely on the provided content, it is impossible to determine the specific product or service FibroBiologics, Inc. offers to address any particular problem, as the content only details cookie usage.

Why now

The specific timing catalyst is unclear from available information.

Source: SEC EDGAR Form D filing